|
Aug 5
|
Stocks to Watch Tuesday: Palantir, Hims, Pfizer, Caterpillar
|
|
Aug 5
|
5 Things to Know Before the Stock Market Opens
|
|
Aug 5
|
These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More
|
|
Aug 5
|
Vertex Stock Tumbles 15% After Strong Earnings. What’s Spooking Investors.
|
|
Aug 5
|
US stock futures higher amid mixed corporate earnings
|
|
Aug 5
|
Vertex Pharmaceuticals Inc (VRTX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Aug 5
|
Vertex plan to build on pain drug breakthrough hits hurdles
|
|
Aug 4
|
Stocks to Watch Monday: Palantir, Hims & Hers, Vertex, Tesla
|
|
Aug 4
|
Compared to Estimates, Vertex (VRTX) Q2 Earnings: A Look at Key Metrics
|
|
Aug 4
|
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates
|
|
Aug 4
|
Vertex Stock Falls After Pain-Drug Setback, Despite Stronger Earnings
|
|
Aug 4
|
Vertex Crashes After Pain Drug Flop Outweighs Second-Quarter Beat
|
|
Aug 4
|
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q2 Sales Beat Estimates But Stock Drops 13.5%
|
|
Aug 4
|
Vertex: Q2 Earnings Snapshot
|
|
Aug 4
|
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
|
|
Aug 4
|
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain
|
|
Aug 4
|
Vertex Reports Second Quarter 2025 Financial Results
|
|
Aug 3
|
What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings
|
|
Aug 2
|
3 Unstoppable Stocks to Buy in August
|
|
Aug 1
|
McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week
|